𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Huntington's disease-like 2 in Brazil—Report of 4 patients

✍ Scribed by Guilherme G. Riccioppo Rodrigues; Ruth H. Walker; Alexis Brice; Cécile Cazeneuve; Odile Russaouen; Helio A.G. Teive; Renato Puppi Munhoz; Nilson Becker; Salmo Raskin; Lineu Cesar Werneck; Wilson Marques Junior; Vitor Tumas


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
225 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Huntington's disease‐like 2 (HDL2) is a neurodegenerative disorder found in people of African ancestry with clinical, radiological, and neuropathological manifestations similar to Huntington's disease (HD). HDL2 is caused by a pathological expansion of CAG/CTG triplets in exon 2A of the JPH3 gene. We describe four cases of HDL2 from four unrelated families, and discuss their clinical findings. HDL2 should be considered in every patient with an HD‐like phenotype who tests negative for the HD mutation, even if African ancestry is not immediately apparent. © 2008 Movement Disorder Society


📜 SIMILAR VOLUMES


Phenotypic features of Huntington's dise
✍ Ruth H. Walker; Joseph Jankovic; Elizabeth O'Hearn; Russell L. Margolis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

## Abstract Huntington's disease‐like 2 is an autosomal dominantly inherited disorder due to an expansion of trinucleotide repeats. It resembles classic Huntington's disease in clinical phenotype, inheritance pattern, and neuropathological features. We highlight the clinical features of this disord

Huntington's disease–like 2 (HDL2) in No
✍ Russell L. Margolis; Susan E. Holmes; Adam Rosenblatt; Lisa Gourley; Elizabeth O 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract Huntington's Disease–like 2 (HDL2) is a progressive, autosomal dominant, neurodegenerative disorder with marked clinical and pathological similarities to Huntington's disease (HD). The causal mutation is a CTG/CAG expansion mutation on chromosome 16q24.3, in a variably spliced exon of j

Validation of self-report depression rat
✍ Jennifer De Souza; Lisa A. Jones; Hugh Rickards 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract The aim of this study was to assess the criterion validity of three self‐report measures of depression in a sample of patients with Huntington's disease (HD). Fifty patients with HD completed the Beck Depression Inventory‐II (BDI‐II), the Hospital Anxiety and Depression Scale (HADS), an

Patient and caregiver quality of life in
✍ Rebecca E. Ready; Melissa Mathews; Anne Leserman; Jane S. Paulsen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

## Abstract Little is known about subjective perceptions of quality of life (QOL) in Huntington's disease (HD). The current study determined correlates of patient and caregiver QOL and assessed change over time. Participants were 22 patient‐caregiver dyads, who rated QOL at baseline and 6 months la